| attributes |
| DNA extraction batch |
batch3 |
| ENA first public |
2017-08-16 |
| ENA last update |
2016-10-21 |
| External Id |
SAMEA3920533 |
| INSDC center alias |
UH/IB |
| INSDC center name |
Institute of Biotechnology, University of Helsinki |
| INSDC first public |
2017-08-16T17:01:50Z |
| INSDC last update |
2016-10-21T09:38:37Z |
| INSDC status |
public |
| Submitter Id |
a50 |
| acne medication |
lymecycline |
| acne severity back |
1 |
| acne severity face |
2 |
| collection date |
2012-06-27 |
| dermatology disorder |
acne,athletes foot |
| environment (biome) |
human-associated habitat |
| environment (feature) |
skin |
| environment (material) |
skin |
| geographic location (country and/or sea) |
Finland |
| geographic location (latitude) |
65.0090556 |
| geographic location (longitude) |
25.5180278 |
| host age |
15 |
| host body site |
back |
| host disease status |
no |
| host sex |
male |
| host subject id |
29T |
| human skin environmental package |
human-skin |
| investigation type |
metagenome |
| pcr primers |
forward: AGAGTTTGATCMTGGCTCAG, reverse: GTATTACCGCGGCTGCTG |
| project name |
Acne microbiome and medication |
| sample collection device or method |
swab |
| sample name |
a50 |
| sampletype |
after_treatment |
| sequencing method |
Illumina MiSeq |
| sequencing run |
run1 |
| target gene |
16S |
| target subfragment |
V1-V3 |
|